Market Place
Sourcing Support
MSN Lab`s Generics Perampanel Receives Tentative Approval in US
16 Dec 2024 //
FDA
BeiGene defends Brukinsa from MSN`s generic threat until 2037
19 Nov 2024 //
FIERCE PHARMA
Judge upholds MSN`s generic Entresto nod amid Novartis challenge
19 Oct 2024 //
FIERCE PHARMA
Novartis loses latest bid to block generic version of blockbuster heart drug
17 Oct 2024 //
REUTERS
Exelixis Updates On Second Patent Litigation Trial With MSN Labs
15 Oct 2024 //
BUSINESSWIRE
MSN`s Generics Nilotinib Receives Tentative Approval in US
02 Oct 2024 //
FDA
MSN`s Generics Nebivolol HCl Receives Approval in US
01 Oct 2024 //
FDA
Polpharma & MSN Lab Announce Strategic Distribution Partnership
23 Sep 2024 //
PRESS RELEASE
MSN`s Generics Clopidogrel Bisulfate Receives Approval in US
20 Sep 2024 //
FDA
MSN`s Generics Clopidogrel Bisulfate Receives Approval in US
20 Sep 2024 //
FDA
MSN Laboratories`s Generics Famotidine Receives Approval in US
06 Aug 2024 //
FDA
MSN Labs` Generic Azacitidine Receives Approval in the U.S.
16 May 2024 //
FDA
MSN`s Generic Lisdexamfetamine Dimesylate Receives Approval in the U.S.
02 Feb 2024 //
FDA
MSN`s Generic Pimavanserin Receives Approval in the U.S.
16 Jan 2024 //
FDA
MSN Lab`s Generic Brivaracetam Receives Approval in the U.S.
09 Nov 2023 //
FDA
MSN Laboratories` Generic Brivaracetam Receives Approval in the U.S.
09 Nov 2023 //
FDA
MSN Laboratories` Generic Trabectedin Receives Approval in the U.S.
02 Oct 2023 //
FDA
MSN`s Generic Losartan Potassium Receives Approval in the U.S.
14 Aug 2023 //
FDA
MSN Lab`s Generic Etelcalcetide Receives Approval in the U.S.
03 Aug 2023 //
FDA
MSN`s Generic Darunavir Receives Approval in the U.S.
05 Jul 2023 //
FDA
MSN`s Generic Obeticholic Acid Receives Receives Approval in the U.S.
30 May 2023 //
FDA
MSN Lab`s Generic Carmustine Receives Receives Approval in the U.S.
11 May 2023 //
FDA
MSN Lab`s Generic Ribociclib Receives Receives Approval in the U.S.
09 May 2023 //
FDA
MSN Lab Generic Letrozole:Ribociclib Receives Approval in the U.S
01 May 2023 //
FDA
MSN`s Generic Doxepin Hydrochloride Receives Approval in the U.S.
03 Apr 2023 //
FDA
MSN`s Generic Acyclovir Receives Approval in the U.S.
09 Mar 2023 //
FDA
MSN`s Generic Afatinib Receives Approval in the U.S.
14 Feb 2023 //
FDA
MSN`s Generic Lacosamide Receives Approval in the U.S.
09 Feb 2023 //
FDA
Exelixis Announces Update on Patent Litigation with MSN Laboratories
19 Jan 2023 //
BUSINESSWIRE
MSN`s Generic Olmesartan Medoxomil Receives Approval in the U.S.
18 Jan 2023 //
FDA
MSN`s Generic Tasimelteon Receives Approval in the U.S.
12 Jan 2023 //
FDA
MSN`s Generic Haloperidol Receives Approval in the U.S.
18 Nov 2022 //
FDA
MSN`s Generic Levetiracetam Receives Approval in the U.S.
15 Nov 2022 //
FDA
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
31 Oct 2022 //
ENDPTS
Novartis files another Entresto patent suit to fight generics
27 Oct 2022 //
FIERCEPHARMA
MSN`s Generic Levetiracetam Receives Approval in the U.S.
07 Oct 2022 //
FDA
MSN`s Generic Isosulfan Blue Receives Approval in the U.S.
16 Sep 2022 //
FDA
MSN`s Generic Ziprasidone Mesylate Receives Approval in the U.S.
15 Sep 2022 //
FDA
MSN`s Generic Lurasidone HCL Receives Approval in the U.S.
09 Sep 2022 //
FDA
MSN`s Generic Vigabatrin Receives Approval in the U.S.
07 Sep 2022 //
FDA
MSN`s Generic Roflumilast Receives Approval in the U.S.
07 Sep 2022 //
FDA
MSN`s Generic Riociguat Receives Approval in the U.S.
01 Sep 2022 //
FDA
MSN`s Generic Darunavir Receives Approval in the U.S.
24 Aug 2022 //
FDA
MSN`s Generic Bumetanide Receives Approval in the U.S.
04 Aug 2022 //
FDA
MSN Laboratories Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
MSN Generic Levetiracetam Receives Approval in the U.S.
15 Jul 2022 //
FDA
MSN Lab`s Generic Pimavanserin Receives Tentative Approval in the U.S
03 Jun 2022 //
FDA
Breckenridge Launches Lacosamide Tablets Manufactured by MSN Laboratories
19 Apr 2022 //
PRNEWSWIRE
MSN Labs` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
MSN`s Generic Sildenafil Citrate Receives Approval in the U.S.
08 Feb 2022 //
FDA
MSN`s Generic Chlorpromazine Hydrochloride Receives Approval in the U.S.
27 Jan 2022 //
FDA
MSN to launch generic anti-COVID pill Molnupiravir under `Molulow` brand
07 Jan 2022 //
ECONOMICTIMES
BI gets injunction against Dr. Reddy’s Labs, MSN Labs for anti-diabetes drug
26 Oct 2021 //
ECONOMICTIMES
MSN Labs launches Empagliflozin tablets for diabetes management in India
18 Oct 2021 //
EXPRESSPHARMA
Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19
09 Oct 2021 //
REUTERS
Aurobindo Pharma, MSN Labs seek DGCI nod for Merck`s molnupiravir
08 Oct 2021 //
ECONOMIC TIMES
MSN labs launch indigenous drug Posaconazole to treat black fungus
21 May 2021 //
INDIATODAY
Lilly signs two pacts with MSN Labs and Torrent Pharma, for Covid drug
14 May 2021 //
THEHINDUBUSINESSLINE
Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole
22 Apr 2021 //
PRNEWSWIRE
